Is Seres Therapeutics Still A Buy After Disappointing SER-287 Topline Results?
Seres Therapeutics (NASDAQ: MCRB) is a microbiome therapeutics company developing a novel class of multifunctional bacterial…
Seres Therapeutics (NASDAQ: MCRB) is a microbiome therapeutics company developing a novel class of multifunctional bacterial…
Nine of 11 sector gauges compiled by the National Stock Exchange ended higher led by the Nifty Realty index’s over 1 per cent…
Don’t let these misconceptions keep you from making millions.
This suggests that bankruptcy is still very much in play for America’s top movie chain.
SouthState Corporation (NASDAQ: SSB) today released its unaudited results of operations and other financial information for the…
One of the stocks has turned $10,000 into nearly $100 million.
“We’re seeing high demand for a wide range of Olympics releases, not just the most recent drops,” StockX senior economist Jesse…
Luxury Italian brand Zegna has decided to go public via special purpose acquisition (SPAC), in an interesting blend of theThe…
Today’s episode is a new installment of “Overrated or Underrated”! In this episode, I give my hot takes on Starbucks, Roblox,…
WINTER HAVEN, Fla. and ATLANTA, July 23, 2021 /PRNewswire/ — SouthState Corporation (NASDAQ: SSB) (“SouthState” or the “Company”)…